ArticleProceedings of the National Academy of Sciences of the United States of America2026

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis.

Adrian Gervais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.